Artificial Intelligence in Medicine

LAU Medical Center-Rizk Hospital - Auditorium D & Online

This special lecture is organized by the LAU Gilbert and Rose-Marie Chagoury School of Medicine. 

Presented by Guest Speaker:
Jean Nehme, MBBS, MRCS, MScDIC
CEO and co-founder of Touch Surgery
Plastic Surgery
London, England, United Kingdom

Moderated by:
Roula Husni Samaha, MD
Clinical Professor
Interim Chair, Department of Internal Medicine
LAU Gilbert and Rose-Marie Chagoury School of Medicine

Rodrigue Chemaly, MD
Clinical Assistant Professor
General Surgery Residency Program Director
Department of Surgery
LAU Gilbert and Rose-Marie Chagoury School of Medicine

In this lecture, the various applications of artificial intelligence in medicine, such as diagnosis, treatment recommendation, predictive analysis, and image analysis will described. How artificial intelligence can leverage patient data, medical literature, and algorithms to help healthcare professionals make accurate and timely clinical decisions will be demonstrated. Additionally, the ethical implications of artificial intelligence in healthcare, including issues of data privacy, patient consent and transparency will be explored. And, relevant laws and regulations regarding the use of artificial intelligence in medicine will be discussed.


Dr. Jean Nehme trained as a plastic surgeon at Imperial College in London. He has over 15 years of experience in healthcare as a physician, entrepreneur, operator, and investor. He has received multiple prize-winning awards for his innovative research, published numerous academic research, and presented at multiple international conferences. Moreover, he acquired multiple global patents in healthcare data and artificial intelligence.
In 2020, Dr. Nehme sold his business Digital Surgery to Medtronic. Digital Surgery pioneered real time computer vision in the operating room, with real-time models that will ultimately bring about automation in surgical procedural delivery. Since 2020, Dr. Nehme has also been investing with a small team in early stage medtech/digital health and life science businesses and has also set up builds from inception and by working with academics to translate deep scientific research. In 2021, Dr. Nehme was critical to working through over 200 plus target companies and ultimately identified, negotiated, and fundraised for target company Allurion, a non-invasive medical device focused on obesity. He is passionate about the future of healthcare with the inclusion of AI and Robotics. 

1 CME/CPD credits will be granted for the School of Medicine faculty members.
Attendance will be recorded by the CME Office. 

To join this event online via WebEx, please click here.
Meeting number: 2365 066 3743
Password: 2RmDbT6Nvb3

All are welcome.